510(k) K912944
K912944 is an FDA 510(k) premarket notification submitted by Mallinckrodt Group, Inc. for the device "CT 8000 DIGITAL INJECTION SYSTEM". The FDA issued a decision of Substantially Equivalent on Feb 4, 1992. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650. Mallinckrodt Group, Inc. has 26 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 4, 1992
- Date Received
- Jul 5, 1991
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Injector And Syringe, Angiographic
- Device Class
- Class II
- Regulation Number
- 870.1650
- Review Panel
- HO
- Submission Type
- 510(k)
Need the full FDA record for Mallinckrodt Group, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.